Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2024 Jan 31;12(1):e005828corr1. doi: 10.1136/jitc-2022-005828corr1

Correction: Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

PMCID: PMC10831446  PMID: 38296600

Franklin C, Mohr P, Bluhm L, et al. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 2023;11:e005828. doi: 10.1136/jitc-2022-005828

In this article, the authorship has been updated. Karin Scharffetter-Kochanek has been replaced by Anca Sindrilaru.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES